Trial intelligence / Profile preview

Desmodium styracifolium total flavone capsule dose-ranging trial in urinary calculi

ChiCTR-TRC-12002583Phase 2Completed

Sponsor
Fujian Provincial People's Hospital
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of total flavonoids of Desmodium styracifolium in Lithiasis, ureterolithiasis and nephrolithiasis (3 arms), sponsored by Fujian Provincial People's Hospital. Primary endpoint: Stone expulsion. Started Apr 2012; status: completed.

02

Drugs

total flavonoids of Desmodium styracifolium
03

Conditions

Lithiasisureterolithiasisnephrolithiasis

Beyond the preview

Go deeper on ChiCTR-TRC-12002583.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002583.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call